Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Aug 21;12(8):e0183586.
doi: 10.1371/journal.pone.0183586. eCollection 2017.

Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis

Ruey Chen  1 , Pi-Tuan Chan  2 , Hsin Chu  3   4   5 , Yu-Cih Lin  1   6 , Pi-Chen Chang  1 , Chien-Yu Chen  6   7   8 , Kuei-Ru Chou  1   9   10
Affiliations
Meta-Analysis

Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis

Ruey Chen et al. PLoS One. .

Abstract

Background: This is the first meta-analysis to compare the treatment effects and safety of administering donepezil alone versus a combination of memantine and donepezil to treat patients with moderate to severe Alzheimer Disease, particularly regarding cognitive functions, behavioral and psychological symptoms in dementia (BPSD), and global functions.

Methods: PubMed, Medline, Embase, PsycINFO, and Cochrane databases were used to search for English and non-English articles for inclusion in the meta-analysis to evaluate the effect size and incidence of adverse drug reactions of different treatments.

Results: Compared with patients who received donepezil alone, those who received donepezil in combination with memantine exhibited limited improvements in cognitive functions (g = 0.378, p < .001), BPSD (g = -0.878, p < .001) and global functions (g = -0.585, p = .004). Gradual titration of memantine plus a fixed dose and gradual titration of donepezil as well as a fixed dose and gradual titration of memantine resulted in limited improvements in cognitive functions(g = 0.371, p = .005), BPSD(g = -0.913, p = .001), and global functions(g = -0.371, p = .001).

Conclusion: Both in the 24th week and at the final evaluation point, the combination of donepezil and memantine led to greater improvement in cognitive functions, BPSD, and global functions than did donepezil alone in patients with moderate to severe Alzheimer Disease.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study selection flow chart.
Fig 2
Fig 2. Forest plots to compare the combination therapy with the monotherapy: Cognitive functions.
Fig 3
Fig 3. Forest plots to compare the combination therapy with the monotherapy: BPSD.
Fig 4
Fig 4. Forest plots to compare the combination therapy with the monotherapy: global functions.
See this image and copyright information in PMC

References

    1. Kumar A, Singh A, Ekavali. A review on Alzheimer's disease pathophysiology and its management: An update. Pharmacol Rep. 2015;67(2):195–203. doi: 10.1016/j.pharep.2014.09.004 - DOI - PubMed
    1. Ehret MJ, Chamberlin KW. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials? Clin Ther. 2015;37(8):1604–16. Epub 2015/07/01. doi: 10.1016/j.clinthera.2015.05.510 . - DOI - PubMed
    1. Deardorff WJ, Feen E, Grossberg GT. The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease. Drugs Aging. 2015;32(7):537–47. Epub 2015/06/03. doi: 10.1007/s40266-015-0273-x. . - DOI - PubMed
    1. Campos C, Rocha NBF, Vieira RT, Rocha SA, Telles-Correia D, Paes F, et al. Treatment of cognitive deficits in Alzheimer's disease: A psychopharmacological review. Psychiatria Danubina. 2016;28(1):2–12. - PubMed
    1. Riverol M, Slachevsky A, López OL. Efficacy and tolerability of a combination treatment of memantine and donepezil for alzheimer's disease: A literature review evidence. European Neurological Journal. 2011;3(1):15–9. - PMC - PubMed

Publication types

MeSH terms